IN2015DN02929A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN02929A IN2015DN02929A IN2929DEN2015A IN2015DN02929A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A IN 2929DEN2015 A IN2929DEN2015 A IN 2929DEN2015A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A
- Authority
- IN
- India
- Prior art keywords
- luliconazole
- solubility
- atoms
- improving
- disclosed
- Prior art date
Links
- YTAOBBFIOAEMLL-REQDGWNSSA-N Luliconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@H](CS\1)SC/1=C(\C#N)N1C=NC=C1 YTAOBBFIOAEMLL-REQDGWNSSA-N 0.000 abstract 2
- 229960000570 luliconazole Drugs 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012202514 | 2012-09-14 | ||
| JP2013131504 | 2013-06-24 | ||
| PCT/JP2013/074775 WO2014042231A1 (en) | 2012-09-14 | 2013-09-06 | Crystal and pharmaceutical preparation containing the same crystal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02929A true IN2015DN02929A (enrdf_load_html_response) | 2015-09-18 |
Family
ID=49237577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2929DEN2015 IN2015DN02929A (enrdf_load_html_response) | 2012-09-14 | 2013-09-06 |
Country Status (7)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010117089A2 (en) | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2416758B8 (en) | 2009-04-09 | 2017-10-18 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| KR101806304B1 (ko) | 2010-06-11 | 2017-12-07 | 가부시키가이샤 폴라 파마 | 항진균성 약학적 조성물 |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| WO2014041708A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5680161B1 (ja) * | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| US10703744B2 (en) | 2014-12-12 | 2020-07-07 | Glenmark Life Sciences Limited | Process for preparation of luliconazole |
| JP5951864B1 (ja) * | 2015-06-05 | 2016-07-13 | 株式会社ポーラファルマ | 抗ジアルジア剤 |
| JP2017101009A (ja) | 2015-12-04 | 2017-06-08 | 株式会社ポーラファルマ | 抗アカントアメーバ剤及びその製造法 |
| TR201714882A2 (tr) | 2017-10-03 | 2019-04-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3081766B2 (ja) | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| JP3278738B2 (ja) * | 1995-07-08 | 2002-04-30 | 日本農薬株式会社 | 抗真菌剤 |
| CA2226214C (en) * | 1995-07-08 | 2007-04-17 | Nihon Nohyaku Co., Ltd. | Antifungal agent, compound therefor, process for producing the same, and method for using the same |
| JP2002114680A (ja) | 2000-07-31 | 2002-04-16 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
| EP2005959B1 (en) * | 2006-03-08 | 2015-01-21 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| WO2007102242A1 (ja) * | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
| EP2025337B1 (en) * | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| EP2191827B1 (en) | 2007-09-05 | 2013-10-30 | Pola Pharma Inc. | Antifungal composition |
| US20100204293A1 (en) | 2007-09-05 | 2010-08-12 | Pola Pharma Inc. | Pharmaceutical composition |
| EP2191828B1 (en) * | 2007-09-05 | 2016-08-10 | Pola Pharma Inc. | Antifungal pharmaceutical composition |
| EP2395839B1 (en) | 2009-02-13 | 2014-05-07 | Topica Pharmaceuticals, Inc | Anti-fungal formulation |
| EP2416758B8 (en) | 2009-04-09 | 2017-10-18 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| WO2010117089A2 (en) | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| KR101806304B1 (ko) | 2010-06-11 | 2017-12-07 | 가부시키가이샤 폴라 파마 | 항진균성 약학적 조성물 |
| US8728210B2 (en) | 2011-07-07 | 2014-05-20 | Hsueh Yuan Lee | Exhaust gas treatment apparatus and method |
| CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
| WO2014041708A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| WO2014042043A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Pharmaceutical composition containing luliconazole |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
-
2013
- 2013-09-06 EP EP13766723.4A patent/EP2895165B1/en active Active
- 2013-09-06 JP JP2013185320A patent/JP5589130B1/ja active Active
- 2013-09-06 US US14/019,997 patent/US9012484B2/en active Active
- 2013-09-06 RU RU2015113638A patent/RU2622644C2/ru active
- 2013-09-06 IN IN2929DEN2015 patent/IN2015DN02929A/en unknown
- 2013-09-06 WO PCT/JP2013/074775 patent/WO2014042231A1/en active Application Filing
- 2013-09-06 CN CN201380018386.2A patent/CN104284662A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015027972A (ja) | 2015-02-12 |
| RU2015113638A (ru) | 2016-11-10 |
| JP5589130B1 (ja) | 2014-09-10 |
| US20140080882A1 (en) | 2014-03-20 |
| WO2014042231A1 (en) | 2014-03-20 |
| EP2895165B1 (en) | 2016-12-14 |
| CN104284662A (zh) | 2015-01-14 |
| RU2622644C2 (ru) | 2017-06-19 |
| EP2895165A1 (en) | 2015-07-22 |
| US9012484B2 (en) | 2015-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN02929A (enrdf_load_html_response) | ||
| PH12016500611A1 (en) | Compositions useful for treating disorders related to kit | |
| IN2015DN02376A (enrdf_load_html_response) | ||
| UA114656C2 (uk) | Похідні піридину | |
| IN2014CN02639A (enrdf_load_html_response) | ||
| CO7111289A2 (es) | Compuestos inhibidores de metaloenzimas | |
| MX2013014564A (es) | Piridin-2-amidas utiles como agonistas canabinoides 2 (cb2). | |
| SG10201805410XA (en) | Therapeutic agent or prophylactic agent for dementia | |
| UA114655C2 (uk) | Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2 | |
| UA116239C2 (uk) | Нові похідні піридину | |
| PH12015501843A1 (en) | Novel pyrazol derivatives | |
| IN2014DN09085A (enrdf_load_html_response) | ||
| MX2013015308A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
| IN2015DN03928A (enrdf_load_html_response) | ||
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| IN2013DE00266A (enrdf_load_html_response) | ||
| UA111333C2 (uk) | Спосіб одержання l-аргінінової солі периндроприлу | |
| AU2014371081A1 (en) | Polyoxalates and a Process for the Production Thereof | |
| MX2014008918A (es) | Nuevos derivados de pirrolidina. | |
| IN2014DN08443A (enrdf_load_html_response) | ||
| AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
| IN2014DN10658A (enrdf_load_html_response) | ||
| IN2014KN01772A (enrdf_load_html_response) | ||
| AU341949S (en) | Cleaning tray | |
| UA75861U (uk) | Спосіб лапароскопічного лікування зовнішнього генітального ендометріозу |